Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Insulin soluble porcine 100u/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Porcine insulin soluble |
Inferred relationship |
Some |
|
Porcine insulin soluble-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Some |
1 |
Porcine insulin soluble-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Some |
1 |
Product containing precisely pork insulin (as porcine insulin soluble) 1000 unit/10 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Porcine insulin soluble |
Inferred relationship |
Some |
1 |
Porcine insulin soluble only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Some |
1 |
Porcine insulin soluble only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Some |
1 |
Product containing precisely pork insulin (as porcine insulin soluble) 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Porcine insulin soluble |
Inferred relationship |
Some |
1 |
Product containing precisely porcine isophane insulin 70 unit/1 milliliter and porcine regular insulin 30 unit/1 milliliter conventional release suspension for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Porcine insulin soluble |
Inferred relationship |
Some |
2 |
Product containing precisely porcine isophane insulin 70 unit/1 milliliter and porcine regular insulin 30 unit/1 milliliter conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Porcine insulin soluble |
Inferred relationship |
Some |
2 |
Product containing precisely porcine regular insulin 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Porcine insulin soluble |
Inferred relationship |
Some |
1 |
Product containing precisely porcine regular insulin 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Porcine insulin soluble |
Inferred relationship |
Some |
1 |
Product containing isophane insulin and porcine regular insulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Some |
2 |
Product containing isophane insulin and porcine regular insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Some |
2 |
Product containing only isophane insulin and porcine regular insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Some |
2 |
Product containing only isophane insulin and porcine regular insulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Some |
2 |
Product containing porcine isophane insulin and porcine regular insulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Some |
2 |
Product containing only porcine isophane insulin and porcine regular insulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Some |
2 |
Product containing porcine isophane insulin and porcine regular insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Some |
2 |
Product containing only porcine isophane insulin and porcine regular insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Some |
2 |